Dogs trained to detect Parkinson’s disease from skin swabs achieve up to 80% sensitivity and 98% specificity, suggesting a ...

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability ...

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the randomized double-blind treatment period of the Vibrance-1 phase 2 study evaluating alixorexton in patients with ...

Dogs' noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect ...

A nationwide clinical trial is offering renewed hope to thousands of Georgia families affected by Alzheimer’s disease.

For many of us, gluten is a dietary villain, capable of causing all sorts of gastrointestinal troubles. Research out this ...

Treatment discontinuation due to adverse events occurred in 20% of patients in the pramipexole group, compared to 5% in the ...

Topline results expected in the third quarter of 2025.SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company ...

Topline results were announced from a phase 3 trial evaluating atogepant vs topiramate in adults with a history of 4 or more migraine days per month.

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

Dogs can be trained to reliably sniff out Parkinson’s disease from a person’s sebum, or skin secretions, a new study found.

A new study from McMaster University researchers has found that many people with irritable bowel syndrome (IBS) who believe ...